Laser hair depilation therapy for pilonidal sinus disease: a 5-year, retrospective experience in a university teaching hospital in the UK, 2017–2023
Clinical and Experimental Dermatology · 2025
DOI: 10.1093/ced/llaf035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, 2025. Verfasst von Kashini Andrew und 7 weiteren Autor:innen. Beteiligte Einrichtung: Birmingham Skin Centre, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK. Hauptthemen laut MEDLINE: Pilonidal Sinus, Hair Removal, Laser Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
Background
Pilonidal sinus disease (PSD) is a chronic, debilitating condition predominantly affecting young men. Laser hair depilation is an established adjunct to surgical treatment for PSD. It can lead to reduced rates of recurrence and postsurgical interventions.
Objectives
To assess the outcome of laser hair depilation therapy on disease progression in patients with PSD at the Birmingham Skin Regional Laser Centre.
Methods
Patient demographics, PSD clinical stage, laser type, number of laser sessions, surgical intervention and treatment outcomes were extracted from electronic medical records of patients (n = 97) referred for laser hair depilation between 2017 and 2023. Statistical analysis was performed using Microsoft Excel and R. Treatment outcomes were categorized as improvement (healed, improved) or no improvement of underlying PSD. Disease severity was classified using the method of Guner et al. (BMC Surg 2016; 16:18).
Results
Most patients affected were male (77%). The median age was 22 years (interquartile range 20–28). The median number of laser hair removal sessions was 8 (interquartile range 5.5–10). The number of laser hair removal sessions was the only predictive factor for symptom resolution (P < 0.001). Neither surgical intervention nor the type of surgery (incision, excision, modified flap, or endoscopic surgical intervention) showed a significant association with improvement in PSD (P = 0.47 and P = 0.65, respectively). In the subgroup of patients who did not undergo surgery (n = 32, 33%), 25 patients (78%) had improvement or healing in their PSD. There were no statistically significant associations between age, type of laser, disease severity and benefit from laser hair removal. No complications were reported and there was only one case of recurrence.
Conclusions
Laser hair depilation is a safe and effective postoperative adjunct treatment for treating sacrococcygeal PSD. For early-stage disease it may offer curative treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Birmingham Skin Centre, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.
- University of Wolverhampton Faculty of Education, Health and Wellbeing, Walsall, UK.
ORCID-Profile: Kashini Andrew
Zitieren
APA
Andrew, K., Dyson, M., Lee, P. C., Sonigra, P., Applewaite, R., Li, D., Thomson, M., & Nevill, A. (2025). Laser hair depilation therapy for pilonidal sinus disease: a 5-year, retrospective experience in a university teaching hospital in the UK, 2017–2023. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llaf035
Vancouver
Andrew K, Dyson M, Lee PC, Sonigra P, Applewaite R, Li D, et al. Laser hair depilation therapy for pilonidal sinus disease: a 5-year, retrospective experience in a university teaching hospital in the UK, 2017–2023. Clinical and Experimental Dermatology. 2025. doi:10.1093/ced/llaf035
BibTeX
@article{Andrew2025,
author = {Andrew, Kashini and Dyson, Maya and Lee, Pui Chi and Sonigra, Pooja and Applewaite, Rona and Li, Danning and Thomson, Michelle and Nevill, Alan},
title = {Laser hair depilation therapy for pilonidal sinus disease: a 5-year, retrospective experience in a university teaching hospital in the UK, 2017–2023},
journal = {Clinical and Experimental Dermatology},
year = {2025},
doi = {10.1093/ced/llaf035}
}
EUVIMED